Since the DRB1*15:01 allele of the HLA-DRB1 gene confers the strongest risk for developing MS, we analyzed methylation differences between DRB1*15:01 carriers and non-carriers. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.